A citation-based method for searching scientific literature

Hussein A Tawbi, Peter A Forsyth, Alain Algazi, Omid Hamid, F Stephen Hodi, Stergios J Moschos, Nikhil I Khushalani, Karl Lewis, Christopher D Lao, Michael A Postow, Michael B Atkins, Marc S Ernstoff, David A Reardon, Igor Puzanov, Ragini R Kudchadkar, Reena P Thomas, Ahmad Tarhini, Anna C Pavlick, Joel Jiang, Alexandre Avila, Sheena Demelo, Kim Margolin. N Engl J Med 2018
Times Cited: 607







List of co-cited articles
893 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Georgina V Long, Victoria Atkinson, Serigne Lo, Shahneen Sandhu, Alexander D Guminski, Michael P Brown, James S Wilmott, Jarem Edwards, Maria Gonzalez, Richard A Scolyer,[...]. Lancet Oncol 2018
467
46

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
Michael A Davies, Philippe Saiag, Caroline Robert, Jean-Jacques Grob, Keith T Flaherty, Ana Arance, Vanna Chiarion-Sileni, Luc Thomas, Thierry Lesimple, Laurent Mortier,[...]. Lancet Oncol 2017
336
30

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Sarah B Goldberg, Scott N Gettinger, Amit Mahajan, Anne C Chiang, Roy S Herbst, Mario Sznol, Apostolos John Tsiouris, Justine Cohen, Alexander Vortmeyer, Lucia Jilaveanu,[...]. Lancet Oncol 2016
633
23

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
Kim Margolin, Marc S Ernstoff, Omid Hamid, Donald Lawrence, David McDermott, Igor Puzanov, Jedd D Wolchok, Joseph I Clark, Mario Sznol, Theodore F Logan,[...]. Lancet Oncol 2012
757
22

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski,[...]. N Engl J Med 2015
21

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
18

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, Amit Mahajan, Roy S Herbst, Anne C Chiang, Rogerio Lilenbaum, Frederick H Wilson, Sacit Bulent Omay, James B Yu,[...]. Lancet Oncol 2020
167
18

Nivolumab in previously untreated melanoma without BRAF mutation.
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier, Jessica C Hassel, Piotr Rutkowski, Catriona McNeil, Ewa Kalinka-Warzocha,[...]. N Engl J Med 2015
15

Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.
Masaaki Yamamoto, Toru Serizawa, Takashi Shuto, Atsuya Akabane, Yoshinori Higuchi, Jun Kawagishi, Kazuhiro Yamanaka, Yasunori Sato, Hidefumi Jokura, Shoji Yomo,[...]. Lancet Oncol 2014
721
14

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Paul D Brown, Karla V Ballman, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Anthony C Whitton, Jeffrey Greenspoon, Ian F Parney, Nadia N I Laack, Jonathan B Ashman,[...]. Lancet Oncol 2017
479
14

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Paul D Brown, Kurt Jaeckle, Karla V Ballman, Elana Farace, Jane H Cerhan, S Keith Anderson, Xiomara W Carrero, Fred G Barker, Richard Deming, Stuart H Burri,[...]. JAMA 2016
759
13

Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.
Jill S Barnholtz-Sloan, Andrew E Sloan, Faith G Davis, Fawn D Vigneau, Ping Lai, Raymond E Sawaya. J Clin Oncol 2004
961
13

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
12

Pembrolizumab versus Ipilimumab in Advanced Melanoma.
Caroline Robert, Jacob Schachter, Georgina V Long, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem,[...]. N Engl J Med 2015
12

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
R A Patchell, P A Tibbs, W F Regine, R J Dempsey, M Mohiuddin, R J Kryscio, W R Markesbery, K A Foon, B Young. JAMA 1998
12

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. N Engl J Med 2019
12

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
Georgina V Long, Uwe Trefzer, Michael A Davies, Richard F Kefford, Paolo A Ascierto, Paul B Chapman, Igor Puzanov, Axel Hauschild, Caroline Robert, Alain Algazi,[...]. Lancet Oncol 2012
626
12

Prognostic factors for survival in melanoma patients with brain metastases.
Michael A Davies, Ping Liu, Susan McIntyre, Kevin B Kim, Nicholas Papadopoulos, Wen-Jen Hwu, Patrick Hwu, Agop Bedikian. Cancer 2011
319
12

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.
Harriet M Kluger, Veronica Chiang, Amit Mahajan, Christopher R Zito, Mario Sznol, Thuy Tran, Sarah A Weiss, Justine V Cohen, James Yu, Upendra Hegde,[...]. J Clin Oncol 2019
132
12

The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Costas D Arvanitis, Gino B Ferraro, Rakesh K Jain. Nat Rev Cancer 2020
369
12

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Eric L Chang, Jeffrey S Wefel, Kenneth R Hess, Pamela K Allen, Frederick F Lang, David G Kornguth, Rebecca B Arbuckle, J Michael Swint, Almon S Shiu, Moshe H Maor,[...]. Lancet Oncol 2009
11

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.
Martin Kocher, Riccardo Soffietti, Ufuk Abacioglu, Salvador Villà, Francois Fauchon, Brigitta G Baumert, Laura Fariselli, Tzahala Tzuk-Shina, Rolf-Dieter Kortmann, Christian Carrie,[...]. J Clin Oncol 2011
11

Epidemiology of brain metastases.
Lakshmi Nayak, Eudocia Quant Lee, Patrick Y Wen. Curr Oncol Rep 2012
608
11

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Priscilla K Brastianos, Scott L Carter, Sandro Santagata, Daniel P Cahill, Amaro Taylor-Weiner, Robert T Jones, Eliezer M Van Allen, Michael S Lawrence, Peleg M Horowitz, Kristian Cibulskis,[...]. Cancer Discov 2015
542
11

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Thanyanan Reungwetwattana, Kazuhiko Nakagawa, Byoung Chul Cho, Manuel Cobo, Eun Kyung Cho, Alessandro Bertolini, Sabine Bohnet, Caicun Zhou, Ki Hyeong Lee, Naoyuki Nogami,[...]. J Clin Oncol 2018
278
11

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
Rashmi K Murthy, Sherene Loi, Alicia Okines, Elisavet Paplomata, Erika Hamilton, Sara A Hurvitz, Nancy U Lin, Virginia Borges, Vandana Abramson, Carey Anders,[...]. N Engl J Med 2020
379
11

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.
Daniel N Cagney, Allison M Martin, Paul J Catalano, Amanda J Redig, Nancy U Lin, Eudocia Q Lee, Patrick Y Wen, Ian F Dunn, Wenya Linda Bi, Stephanie E Weiss,[...]. Neuro Oncol 2017
237
11

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.
G A McArthur, M Maio, A Arance, P Nathan, C Blank, M-F Avril, C Garbe, A Hauschild, D Schadendorf, O Hamid,[...]. Ann Oncol 2017
113
11

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
Paul W Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal Aizer, Nancy U Lin, Eric Nesbit, Tim J Kruser, Jason Chan, Steve Braunstein,[...]. J Clin Oncol 2020
60
18

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
10

Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Anita Mahajan, Salmaan Ahmed, Mary Frances McAleer, Jeffrey S Weinberg, Jing Li, Paul Brown, Stephen Settle, Sujit S Prabhu, Frederick F Lang, Nicholas Levine,[...]. Lancet Oncol 2017
297
10

Improved overall survival in melanoma with combined dabrafenib and trametinib.
Caroline Robert, Boguslawa Karaszewska, Jacob Schachter, Piotr Rutkowski, Andrzej Mackiewicz, Daniil Stroiakovski, Michael Lichinitser, Reinhard Dummer, Florent Grange, Laurent Mortier,[...]. N Engl J Med 2015
10

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.
Caroline Robert, Antoni Ribas, Jacob Schachter, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona M McNeil, Michal Lotem,[...]. Lancet Oncol 2019
418
10

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Paul D Brown, Vinai Gondi, Stephanie Pugh, Wolfgang A Tome, Jeffrey S Wefel, Terri S Armstrong, Joseph A Bovi, Cliff Robinson, Andre Konski, Deepak Khuntia,[...]. J Clin Oncol 2020
226
10

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.
Hidefumi Aoyama, Hiroki Shirato, Masao Tago, Keiichi Nakagawa, Tatsuya Toyoda, Kazuo Hatano, Masahiro Kenjyo, Natsuo Oya, Saeko Hirota, Hiroki Shioura,[...]. JAMA 2006
10

Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.
Angela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, Bryan H Burmeister, Serigne N Lo, Lauren E Haydu, Janette L Vardy, Anna K Nowak, Haryana M Dhillon, Tasnia Ahmed,[...]. J Clin Oncol 2019
41
24

A randomized trial of surgery in the treatment of single metastases to the brain.
R A Patchell, P A Tibbs, J W Walsh, R J Dempsey, Y Maruyama, R J Kryscio, W R Markesbery, J S Macdonald, B Young. N Engl J Med 1990
9


Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
Paul D Brown, Stephanie Pugh, Nadia N Laack, Jeffrey S Wefel, Deepak Khuntia, Christina Meyers, Ali Choucair, Sherry Fox, John H Suh, David Roberge,[...]. Neuro Oncol 2013
478
9

Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
Paul R Lockman, Rajendar K Mittapalli, Kunal S Taskar, Vinay Rudraraju, Brunilde Gril, Kaci A Bohn, Chris E Adkins, Amanda Roberts, Helen R Thorsheim, Julie A Gaasch,[...]. Clin Cancer Res 2010
430
9

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
Solange Peters, D Ross Camidge, Alice T Shaw, Shirish Gadgeel, Jin S Ahn, Dong-Wan Kim, Sai-Hong I Ou, Maurice Pérol, Rafal Dziadziuszko, Rafael Rosell,[...]. N Engl J Med 2017
9

Brain immunology and immunotherapy in brain tumours.
John H Sampson, Michael D Gunn, Peter E Fecci, David M Ashley. Nat Rev Cancer 2020
169
9

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Nancy U Lin, Virginia Borges, Carey Anders, Rashmi K Murthy, Elisavet Paplomata, Erika Hamilton, Sara Hurvitz, Sherene Loi, Alicia Okines, Vandana Abramson,[...]. J Clin Oncol 2020
143
9

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
Jacob Schachter, Antoni Ribas, Georgina V Long, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S Carlino, Catriona McNeil, Michal Lotem,[...]. Lancet 2017
666
8

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
L Gaspar, C Scott, M Rotman, S Asbell, T Phillips, T Wasserman, W G McKenna, R Byhardt. Int J Radiat Oncol Biol Phys 1997
8

PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
8

Brain metastases.
Achal Singh Achrol, Robert C Rennert, Carey Anders, Riccardo Soffietti, Manmeet S Ahluwalia, Lakshmi Nayak, Solange Peters, Nils D Arvold, Griffith R Harsh, Patricia S Steeg,[...]. Nat Rev Dis Primers 2019
259
8

Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.
Shirish M Gadgeel, Rimas V Lukas, Jerome Goldschmidt, Paul Conkling, Keunchil Park, Diego Cortinovis, Filippo de Marinis, Achim Rittmeyer, Jyoti D Patel, Joachim von Pawel,[...]. Lung Cancer 2019
80
10

Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Lucio Crinò, Giuseppe Bronte, Paolo Bidoli, Paola Cravero, Elisa Minenza, Enrico Cortesi, Marina C Garassino, Claudia Proto, Federico Cappuzzo, Francesco Grossi,[...]. Lung Cancer 2019
83
9

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, Willy Hugo, Alexander H Lee, Tom B Davidson, Anthony C Wang, Benjamin M Ellingson, Julie A Rytlewski, Catherine M Sanders,[...]. Nat Med 2019
486
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.